Ocular Therapeutix (OCUL) EBITDA (2013 - 2026)
Ocular Therapeutix (OCUL) reported EBITDA of -$80.26 million for Q2 2026, compared with -$66.62 million a year earlier.
Powered by 
Analysis
Ocular Therapeutix (OCUL) EBITDA (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ocular Therapeutix's EBITDA came in at -$308.46 million; for FY2025, it was -$265.69 million.
- By year, EBITDA came in at -$168 million in FY2024, -$79.4 million in FY2023, -$76.55 million in FY2022 and -$75.62 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$92.06 million in Q1 2026 and a high of -$17.28 million in Q1 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$92.06 million (Q1 2026), -$68.51 million (Q4 2025) and -$67.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | -80.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -80.26 Mn |
| Mar 31, 2026 | -92.06 Mn |
| Dec 31, 2025 | -68.51 Mn |
| Sep 30, 2025 | -67.63 Mn |
| Jun 30, 2025 | -66.62 Mn |
| Mar 31, 2025 | -62.94 Mn |
| Dec 31, 2024 | -49.63 Mn |
| Sep 30, 2024 | -45.04 Mn |
| Jun 30, 2024 | -42.63 Mn |
| Mar 31, 2024 | -30.70 Mn |
| Dec 31, 2023 | -19.09 Mn |
| Sep 30, 2023 | -18.32 Mn |
| Jun 30, 2023 | -19.92 Mn |
| Mar 31, 2023 | -22.07 Mn |
| Dec 31, 2022 | -18.87 Mn |
| Sep 30, 2022 | -21.04 Mn |
| Jun 30, 2022 | -19.36 Mn |
| Mar 31, 2022 | -17.28 Mn |
| Dec 31, 2021 | -17.48 Mn |
| Sep 30, 2021 | -18.94 Mn |
API Access
Ocular Therapeutix EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();